BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 28623394)

  • 21. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
    Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
    Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffuse alveolar hemorrhage is most often fatal and is affected by graft source, conditioning regimen toxicity, and engraftment kinetics.
    Keklik F; Alrawi EB; Cao Q; Bejanyan N; Rashidi A; Lazaryan A; Arndt P; Dincer EH; Bachanova V; Warlick ED; MacMillan ML; Arora M; Miller J; Brunstein CG; Weisdorf DJ; Ustun C
    Haematologica; 2018 Dec; 103(12):2109-2115. PubMed ID: 30076172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of Allogenic Hematopoietic Stem Cell Transplantation in Fanconi Anemia Caused by Bone Marrow Failure: Single-Regimen, Single-Center Experience of 14 Years.
    Tuysuz G; Guler E; Ozel D; Kupesiz A
    Biol Blood Marrow Transplant; 2019 Oct; 25(10):2017-2023. PubMed ID: 31199982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation.
    Srinivasan R; Takahashi Y; McCoy JP; Espinoza-Delgado I; Dorrance C; Igarashi T; Lundqvist A; Barrett AJ; Young NS; Geller N; Childs RW
    Br J Haematol; 2006 May; 133(3):305-14. PubMed ID: 16643433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unrelated donor cord blood transplantation for non-malignant disorders in children and adolescents.
    Park M; Lee YH; Kang HR; Lee JW; Kang HJ; Park KD; Shin HY; Ahn HS; Baek HJ; Kook H; Hwang TJ; Lee JW; Chung NG; Cho B; Kim HK; Lee SH; Yoo KH; Sung KW; Koo HH; Koh KN; Im HJ; Seo JJ; Park JE; Lim YJ; Lyu CJ; Lee JM; Hah JO;
    Pediatr Transplant; 2014 Mar; 18(2):221-9. PubMed ID: 24372660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.
    Vlachos A; Rosenberg PS; Atsidaftos E; Alter BP; Lipton JM
    Blood; 2012 Apr; 119(16):3815-9. PubMed ID: 22362038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inherited bone marrow failure syndromes in 2012.
    Sakaguchi H; Nakanishi K; Kojima S
    Int J Hematol; 2013 Jan; 97(1):20-9. PubMed ID: 23271412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomere length in inherited bone marrow failure syndromes.
    Alter BP; Giri N; Savage SA; Rosenberg PS
    Haematologica; 2015 Jan; 100(1):49-54. PubMed ID: 25304614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced Intensity Bone Marrow Transplantation with Post-Transplant Cyclophosphamide for Pediatric Inherited Immune Deficiencies and Bone Marrow Failure Syndromes.
    Klein OR; Bapty S; Lederman HM; Younger MEM; Zambidis ET; Jones RJ; Cooke KR; Symons HJ
    J Clin Immunol; 2021 Feb; 41(2):414-426. PubMed ID: 33159275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inherited bone marrow failure syndromes: considerations pre- and posttransplant.
    Alter BP
    Blood; 2017 Nov; 130(21):2257-2264. PubMed ID: 29167174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful engraftment with fludarabine, cyclophosphamide, and thymoglobulin conditioning regimen in unrelated transplantation for severe aplastic anemia: A phase II prospective multicenter study.
    Kang HJ; Shin HY; Park JE; Chung NG; Cho B; Kim HK; Kim SY; Lee YH; Lim YT; Yoo KH; Sung KW; Koo HH; Im HJ; Seo JJ; Park SK; Ahn HS;
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1582-8. PubMed ID: 20685256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Otologic manifestations of Fanconi anemia and other inherited bone marrow failure syndromes.
    Kalejaiye A; Giri N; Brewer CC; Zalewski CK; King KA; Adams CD; Rosenberg PS; Kim HJ; Alter BP
    Pediatr Blood Cancer; 2016 Dec; 63(12):2139-2145. PubMed ID: 27428025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT).
    AlDawsari G; Elhaddad A; El Fakih R; Ben Othman T; Ahmed P; Ghavamzadeh A; Bazarbachi A; Dasouki MJ; Fathy G; Alzahrani H; Samra M; Torjemane L; Satti TM; Shaheen M; Alfraih F; Ayas M; Alahmari A; Alhayli S; Nassar A; Abboud M; Abdelfattah R; El Solh H; Hashmi S; Elhassan T; Ahmed SO; Aljurf M
    Bone Marrow Transplant; 2020 Jul; 55(7):1485-1490. PubMed ID: 32024988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita.
    Dietz AC; Orchard PJ; Baker KS; Giller RH; Savage SA; Alter BP; Tolar J
    Bone Marrow Transplant; 2011 Jan; 46(1):98-104. PubMed ID: 20383216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Reduced-Intensity Conditioning Regimen for Patients with Dyskeratosis Congenita Undergoing Hematopoietic Stem Cell Transplantation.
    Nelson AS; Marsh RA; Myers KC; Davies SM; Jodele S; O'Brien TA; Mehta PA
    Biol Blood Marrow Transplant; 2016 May; 22(5):884-8. PubMed ID: 26845033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of human umbilical cord derived mesenchymal stem cell therapy in children with severe aplastic anemia following allogeneic hematopoietic stem cell transplantation: a retrospective case series of 37 patients.
    Si Y; Yang K; Qin M; Zhang C; Du Z; Zhang X; Liu Y; Yue Y; Feng Z
    Pediatr Hematol Oncol; 2014 Feb; 31(1):39-49. PubMed ID: 24383400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in hematopoietic cell transplantation for inherited bone marrow failure syndromes.
    Sakaguchi H; Yoshida N
    Int J Hematol; 2022 Jul; 116(1):16-27. PubMed ID: 35633493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplant in Aplastic Anemia Using Combined Granulocyte Colony-Stimulating Factor Primed Blood and Bone Marrow Stem Cells: A Retrospective Analysis.
    Ali N; Butt A; Altaf B; Adil SN; Shaikh MU
    Transplant Proc; 2021; 53(1):386-390. PubMed ID: 32773285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia.
    Yoshimi A; Strahm B; Baumann I; Furlan I; Schwarz S; Teigler-Schlegel A; Walther JU; Schlegelberger B; Göhring G; Nöllke P; Führer M; Niemeyer CM
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):425-9. PubMed ID: 24316460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal manifestations of inherited bone marrow failure syndromes.
    Khincha PP; Savage SA
    Semin Fetal Neonatal Med; 2016 Feb; 21(1):57-65. PubMed ID: 26724991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.